In-vitro concentration of azithromycin in human phagocytic cells

J Antimicrob Chemother. 1993 Jun:31 Suppl E:1-4. doi: 10.1093/jac/31.suppl_e.1.

Abstract

The in-vitro intraphagocytic uptake and retention of azithromycin in both human polymorphonuclear leucocytes (PMN) and alveolar macrophages was measured by an improved high-performance liquid chromatography (HPLC) method that was approximately three-fold more sensitive than previous methods. Azithromycin was accumulated in PMN and alveolar macrophages (about 300-fold), with maximum uptake being obtained after incubation for 60 min. Azithromycin was eliminated only partially from the cells during the washing process, and was released slowly during re-incubation of phagocytic cells in antibiotic-free medium. This intracellular retention distinguishes azithromycin from most of the macrolides and quinolones which, in spite of high I/E ratios, are released rapidly from cells.

MeSH terms

  • Azithromycin
  • Chromatography, High Pressure Liquid
  • Erythromycin / analogs & derivatives*
  • Erythromycin / blood
  • Erythromycin / pharmacokinetics
  • Humans
  • Intracellular Fluid / chemistry
  • Intracellular Fluid / metabolism
  • Macrophages, Alveolar / chemistry*
  • Macrophages, Alveolar / metabolism
  • Neutrophils / chemistry*
  • Neutrophils / metabolism

Substances

  • Erythromycin
  • Azithromycin